Deborah Kuk - Concepedia

Author

Deborah Kuk

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

D Kuk, D. Kuk, Deborah Kuk, Kuk, D., U Leung

124

Publications

8.1K

Citations

H-Index

100

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University Columbia University Irving Medical Center University of California, San Francisco Flatiron Health (United States)

About

Deborah Kuk is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	32	4K
2	Health Sciences	9	9	516
3	Engineering	2	2	252
4	Public Health	2	2	140
5	Allergy	1	1	130

Deborah Kuk

Publications

7.9K

Citations

H-Index

Page 1

	Year	Citations
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response Alexander C. Huang, Michael A. Postow, Robert J. Orlowski, Nature Burden RatioCancer ImmunosurveillanceMedicineImmunologyTumor Immunity	2017	1.6K
Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma Peter J. Allen, Deborah Kuk, Carlos Fernández-del Castillo, Annals of Surgery	2016	478
Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma Marcus Tan, Murray F. Brennan, Deborah Kuk, Annals of Surgery	2015	356
Integrated NY-ESO-1 antibody and CD8<sup>+</sup>T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab Jianda Yuan, Matthew Adamow, Brian Ginsberg, Proceedings of the National Academy of Sciences	2011	325
The efficacy of anti‐PD‐1 agents in acral and mucosal melanoma Alexander N. Shoushtari, Rodrigo Ramella Munhoz, Deborah Kuk, Cancer	2016	298
Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment Sandra P. D’Angelo, Alexander N. Shoushtari, Narasimhan P. Agaram, Human Pathology Tumor BiologyCancer ImmunosurveillancePd-l1 ExpressionImmunologyImmunoediting	2014	289
An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer Iain J. Nixon, Laura Y. Wang, Jocelyn Migliacci, Thyroid	2016	224
Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis Deborah Kuk, Alexander N. Shoushtari, Christopher A. Barker, The Oncologist	2016	197
Near universal detection of alterations in <scp><i>CTNNB1</i></scp> and <scp>Wnt</scp> pathway regulators in desmoid‐type fibromatosis by whole‐exome sequencing and genomic analysis Aimeé M. Crago, Juliann Chmielecki, Mara Rosenberg, Genes Chromosomes and Cancer	2015	165
Associations Between Mutations and Histologic Patterns of Mucin in Lung Adenocarcinoma Kyuichi Kadota, Yi‐Chen Yeh, Sandra P. D’Angelo, The American Journal of Surgical Pathology Invasive Mucinous AdenocarcinomaLung AdenocarcinomaPathologyTumor BiologyOncology	2014	164

Page 1